News Related to Keppra®

Related coverage linked through entity extraction aliases.

Anti-Seizure Drug Levetiracetam Shows Promise in Preventing Alzheimer's Disease

Mar 20, 2026

Northwestern University researchers found that levetiracetam, an FDA-approved anti-seizure medication, prevents formation of toxic amyloid-beta 42 peptides in the brain, offering a potential strategy for early Alzheimer's prevention.

FDA Clears First-in-Human Trial of Allogeneic Cell Therapy for Drug-Resistant Epilepsy

Mar 14, 2026

The FDA has authorized the first human trial of an allogeneic stem cell therapy for epilepsy, developed by Shanghai-based Unixell Biotechnology. The therapy uses donor-derived stem cells to produce GABA and suppress seizures in drug-resistant patients.